Refine
Year of publication
- 2024 (48)
- 2023 (92)
- 2022 (136)
- 2021 (136)
- 2020 (169)
- 2019 (196)
- 2018 (169)
- 2017 (154)
- 2016 (157)
- 2015 (162)
- 2014 (160)
- 2013 (171)
- 2012 (162)
- 2011 (183)
- 2010 (181)
- 2009 (179)
- 2008 (150)
- 2007 (137)
- 2006 (129)
- 2005 (122)
- 2004 (150)
- 2003 (95)
- 2002 (123)
- 2001 (103)
- 2000 (102)
- 1999 (109)
- 1998 (98)
- 1997 (96)
- 1996 (81)
- 1995 (78)
- 1994 (87)
- 1993 (59)
- 1992 (54)
- 1991 (29)
- 1990 (39)
- 1989 (44)
- 1988 (56)
- 1987 (32)
- 1986 (19)
- 1985 (33)
- 1984 (22)
- 1983 (20)
- 1982 (29)
- 1981 (20)
- 1980 (36)
- 1979 (24)
- 1978 (34)
- 1977 (14)
- 1976 (13)
- 1975 (12)
- 1974 (3)
- 1973 (2)
- 1972 (2)
- 1971 (1)
- 1968 (1)
Institute
- Fachbereich Medizintechnik und Technomathematik (1571)
- Fachbereich Elektrotechnik und Informationstechnik (712)
- IfB - Institut für Bioengineering (566)
- Fachbereich Energietechnik (562)
- Fachbereich Chemie und Biotechnologie (539)
- INB - Institut für Nano- und Biotechnologien (533)
- Fachbereich Luft- und Raumfahrttechnik (481)
- Fachbereich Maschinenbau und Mechatronik (267)
- Fachbereich Wirtschaftswissenschaften (207)
- Solar-Institut Jülich (161)
Has Fulltext
- no (4713) (remove)
Language
- English (4713) (remove)
Document Type
- Article (3205)
- Conference Proceeding (1039)
- Part of a Book (195)
- Book (146)
- Doctoral Thesis (32)
- Conference: Meeting Abstract (29)
- Patent (25)
- Other (10)
- Report (10)
- Conference Poster (5)
Keywords
- Gamification (6)
- avalanche (6)
- Earthquake (5)
- Enterprise Architecture (5)
- MINLP (5)
- solar sail (5)
- Additive manufacturing (4)
- Diversity Management (4)
- Energy storage (4)
- Engineering optimization (4)
The invention relates to a method for production of single-stranded macronucleotides by amplifying and ligating an extended monomeric single-stranded target nucleic acid sequence (targetss) into a repetitive cluster of double-stranded target nucleic acid sequences (targetds), and subsequently cloning the construct into a vector (aptagene vector). The aptagene vector is transformed into host cells for replication of the aptagene and isolated in order to optain single-stranded target sequences (targetss). The invention also relates to single-stranded nucleic acids, produced by a method of the invention.
Hollow core fiber delivery of sub-ps pulses from a TruMicro 5000 Femto edition thin disk amplifier
(2015)
The use of transgenic animal models has transformed our knowledge of complex biochemical pathways in vivo. It has allowed disease processes to be modelled and used in the development of new disease prevention and treatment strategies. They can also be used to define cell- and tissue-specific pathways of gene regulation. A further major application is in the area of preclinical development where such models can be used to define pathways of chemical toxicity, and the pathways that regulate drug disposition. One major application of this approach is the humanisation of mice for the proteins that control drug metabolism and disposition. Such models can have numerous applications in the development of drugs and in their more sophisticated use in the clinic.